Anthrax Vaccine Market Outlook 2025–2029: Emerging Opportunities and Key Drivers

Uncover key drivers, emerging technologies, and competitive movements shaping the anthrax vaccine market from 2025–2034 with trusted insights from The Business Research Company

What Is The Present Size Of The Anthrax Vaccine Market And What Value Is Projected For 2029?

The intravenous iron drugs market size has seen rapid expansion in recent years. This market is set to increase from $3.44 billion in 2024 to $3.81 billion in 2025, achieving a compound annual growth rate (CAGR) of 10.6%. The historical growth of the market can be linked to the increasing prevalence of iron deficiency anemia, the rising prevalence of chronic diseases, growing healthcare spending, an aging population, and a higher incidence of target illnesses.

The intravenous iron drugs market is anticipated to experience substantial expansion in the coming years, with its size projected to reach $5.73 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 10.8%. This growth during the forecast period can be attributed to several factors including government initiatives, ongoing research and development in the field of IV iron drugs, a rising demand for intravenous iron medicines, an increasing number of research and development activities, and enhancements in administration and formulation. Key trends expected in the forecast period involve advanced intravenous iron therapies, continued advancements in drug development, a move towards more convenient IV iron treatments, strategic collaborations, partnerships, and acquisitions, alongside innovations in novel drug delivery systems.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23430&type=smp

What Factors Are Boosting The Anthrax Vaccine Market?

The increasing occurrence of chronic kidney disease (CKD) is projected to boost the expansion of the intravenous iron drugs market moving ahead. Chronic kidney disease (CKD) describes a progressive decline in kidney function over time, resulting in the kidneys losing their capacity to properly remove waste and surplus fluids from the bloodstream. This rise in chronic kidney disease (CKD) cases stems from higher rates of diabetes and hypertension, conditions that progressively harm the kidneys. Intravenous iron drugs assist individuals with chronic kidney disease by restoring iron reserves, correcting anemia, and elevating hemoglobin levels, thereby facilitating oxygen transport and lessening the reliance on erythropoiesis-stimulating agents. For example, data from June 2024 by the Australian Institute of Health and Welfare, an Australia-based government entity, revealed that chronic kidney disease (CKD) death rates increased by 4.2% in 2021 and 6.2% in 2022. In 2022, CKD accounted for approximately 22,000 deaths in Australia, representing 11% of all mortalities. Consequently, the increasing prevalence of chronic kidney disease (CKD) is fueling the expansion of the intravenous iron drugs market.

What Are The Core Segmentation Criteria In The Anthrax Vaccine Market?

The intravenous iron drugs market covered in this report is segmented –

1) By Product Type: Iron Dextran, Iron Sucrose, Ferric Carboxymaltose, Other Product Types

2) By Indication: Chronic Kidney Disease, Inflammatory Bowel Disease, Cancer, Other Diseases

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Iron Dextran: Low Molecular Weight Iron Dextran, High Molecular Weight Iron Dextran

2) By Iron Sucrose: Standard Iron Sucrose Injection, Iron Sucrose Complex

3) By Ferric Carboxymaltose: Single-Dose Ferric Carboxymaltose, Multiple-Dose Ferric Carboxymaltose

4) By Other Product Types: Ferumoxytol, Ferric Derisomaltose, Sodium Ferric Gluconate

Which Emerging Trends Are Reshaping The Anthrax Vaccine Market Landscape?

Leading companies in the intravenous iron drugs market are prioritizing the development of innovative therapies, such as intravenous (IV) iron replacement therapy, to enhance efficacy, safety, and patient outcomes. Intravenous (IV) iron replacement therapy serves as a medical intervention that directly administers iron into the bloodstream through an intravenous infusion. This treatment is employed for iron deficiency and anemia, especially in patients who are unable to tolerate or adequately absorb oral iron supplements. For example, in June 2023, Daiichi Sankyo Company Limited, a Japan-based pharmaceutical entity specializing in innovative drug development and healthcare solutions, announced that the U.S. Food and Drug Administration (FDA) had given its approval for Injectafer (ferric carboxymaltose injection) for managing iron deficiency in adult patients suffering from heart failure classified as New York Heart Association class II/III, aiming to improve their exercise capacity. Injectafer is a widely recognized intravenous iron therapy known for its effectiveness in quickly replenishing iron levels in patients who either cannot tolerate oral iron supplements or do not respond well to them.

Which Players Are Shaping The Competitive Landscape Of The Anthrax VaccineXX Market?

Major companies operating in the intravenous iron drugs market are AbbVie Inc., Sanofi S.A., Amgen Inc., Fresenius SE & Co. KGaA, Teva Pharmaceutical Industries Ltd., CSL Limited, Sandoz Group AG., Daiichi Sankyo Company Ltd., Sun Pharmaceutical Industries Ltd., Galenica Ltd., Dr.Reddy’s Laboratories, Hikma Pharmaceuticals plc, Zydus Lifesciences Limited, Biocon Limited, Kissei Pharmaceutical Co. Ltd., American Regent Inc., Akebia Therapeutics Inc., Rockwell Medical Inc., Pharmacosmos A/S, Shield Therapeutics plc, Mitsubishi Tanabe Pharma Corporation

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/intravenous-iron-drugs-global-market-report

What Regional Trends Are Shaping Growth In The Anthrax Vaccine Market?

North America was the largest region in the intravenous iron drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous iron drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=23430&type=smp

Browse Through More Reports Similar to the Global Anthrax Vaccine Market 2025, By The Business Research Company

Iron Ore Pellets Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/iron-ore-pellets-global-market-report

Iron And Steel Mills And Ferroalloy Market 2025

https://www.thebusinessresearchcompany.com/report/iron-and-steel-mills-and-ferroalloy-market

Iron And Steel Casting Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/iron-and-steel-casting-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795